Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

August’s top stories: Pfizer-AstraZeneca $1.5bn deal, Cinven buys Bioclinica for $1.4bn

Pfizer has agreed to acquire AstraZeneca's anti-infectives business for $1.5bn, Cinven is to acquire US clinical trial services provider Bioclinica in $1.4bn deal, and India has developed the world’s first leprosy vaccine. Pharmaceutical Technology wraps up key headlines from August.

Go Top